Delivery Order SPE2DB20D1100-SPE2DB25FC1J3
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Citalopram HBR 40 mg tablets. The $9,423.28 Firm Fixed Price Delivery Order has an ultimate completion date of July 12, 2024. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.98 firm fixed-price delivery order is for 4,566,064,257 units of Citalopram HBR 40 mg tablets, with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,235.59 delivery order contract is for the supply of 4,568,107,765 units of Citalopram HBR 40 mg tablets. The contract has a firm fixed price pricing type and a performance period ending on May 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of citalopram HBR 40 mg tablets. The contract has a ceiling value of $6,231.82 and runs through January 10, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $20,622.55, is a delivery order awarded by the Defense Logistics Agency (DLA) for the supply of 4,566,066,792 tablets of Citalopram HBR 40 mg. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,670.19 delivery order contract is for the supply of 4,566,612,973 units of Citalopram HBR 40 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing...
The U.S. Defense Logistics Agency (DLA) awarded a $5,292.46 firm-fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to supply 4,565,406,862 tablets of Citalopram HBR 40 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...